Biofrontera Inc. (BFRI)
(Real Time Quote from BATS)
$1.11 USD
-0.10 (-8.26%)
Updated May 16, 2024 01:32 PM ET
4-Sell of 5 4
F Value D Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Biofrontera Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -20.13 | -0.64 | -37.71 | -10.99 | NA |
Depreciation/Amortization & Depletion | 1.06 | 1.17 | 0.54 | 0.56 | NA |
Net Change from Assets/Liabilities | -4.39 | 2.79 | -1.51 | -2.83 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | -1.43 | -19.52 | 11.96 | 0.88 | NA |
Net Cash From Operating Activities | -24.90 | -16.20 | -26.72 | -12.37 | NA |
Property & Equipment | -0.01 | -0.04 | -0.01 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 0.62 | -5.12 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | 0.62 | -5.16 | -0.01 | 0.00 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.51 | 14.02 | 43.19 | 0.00 | NA |
Issuance (Repayment) of Debt | 3.80 | 0.00 | 0.00 | 8.79 | NA |
Increase (Decrease) Short-Term Debt | 0.10 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 4.40 | NA |
Net Cash from Financing Activities | 8.41 | 14.02 | 43.19 | 13.19 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -15.87 | -7.33 | 16.47 | 0.83 | NA |
Cash at Beginning of Period | 17.41 | 24.74 | 8.28 | 7.45 | NA |
Cash at End of Period | 1.54 | 17.41 | 24.74 | 8.28 | NA |
Diluted Net EPS | -13.02 | -0.60 | -85.60 | NA | NA |
Fiscal Year End for Biofrontera Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -20.13 | -23.66 | -17.32 | -7.48 |
Depreciation/Amortization & Depletion | NA | 1.06 | 0.77 | 0.52 | 0.27 |
Net Change from Assets/Liabilities | NA | -4.39 | 0.85 | -1.01 | 1.36 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -1.43 | 6.01 | 3.79 | 2.17 |
Net Cash From Operating Activities | NA | -24.90 | -16.03 | -14.03 | -3.69 |
Property & Equipment | NA | -0.01 | -0.01 | -0.01 | -0.01 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.62 | 0.56 | 0.18 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 0.62 | 0.55 | 0.16 | -0.01 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 4.51 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 3.80 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.10 | 1.70 | 1.11 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 8.41 | 1.70 | 1.11 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -15.87 | -13.79 | -12.76 | -3.70 |
Cash at Beginning of Period | NA | 17.41 | 17.41 | 17.41 | 17.41 |
Cash at End of Period | NA | 1.54 | 3.62 | 4.65 | 13.71 |
Diluted Net EPS | NA | 4.45 | -4.64 | -7.23 | -5.60 |